$ACAD News Article - Newly Published Retrospective Analysis Showed Lower All-Cause Mortality Risk Among Parkinson's Disease Psychosis Patients Treated with NUPLAZID (pimavanserin) Compared to Those Treated with Other Atypical Antipsychotics https://marketwirenews.com/news-releases/newl...96414.html